nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Benazepril—MTHFR—Parkinson's disease	0.0212	0.743	CrCbGaD
Solifenacin—Mequitazine—CYP2D6—Parkinson's disease	0.00735	0.257	CrCbGaD
Solifenacin—CHRM4—head—Parkinson's disease	0.00127	0.0619	CbGeAlD
Solifenacin—CHRM4—nervous system—Parkinson's disease	0.00121	0.0587	CbGeAlD
Solifenacin—CHRM2—forebrain—Parkinson's disease	0.00119	0.058	CbGeAlD
Solifenacin—CHRM4—central nervous system—Parkinson's disease	0.00116	0.0565	CbGeAlD
Solifenacin—CHRM1—forebrain—Parkinson's disease	0.00108	0.0528	CbGeAlD
Solifenacin—CHRM2—cardiovascular system—Parkinson's disease	0.00101	0.0491	CbGeAlD
Solifenacin—CHRM5—head—Parkinson's disease	0.000994	0.0484	CbGeAlD
Solifenacin—CHRM3—forebrain—Parkinson's disease	0.000971	0.0473	CbGeAlD
Solifenacin—CHRM5—nervous system—Parkinson's disease	0.000943	0.0459	CbGeAlD
Solifenacin—CHRM4—brain—Parkinson's disease	0.000922	0.0449	CbGeAlD
Solifenacin—CHRM1—cardiovascular system—Parkinson's disease	0.000917	0.0447	CbGeAlD
Solifenacin—CHRM5—central nervous system—Parkinson's disease	0.000907	0.0442	CbGeAlD
Solifenacin—CHRM5—brain—Parkinson's disease	0.00072	0.0351	CbGeAlD
Solifenacin—CHRM2—head—Parkinson's disease	0.000682	0.0332	CbGeAlD
Solifenacin—CHRM2—nervous system—Parkinson's disease	0.000647	0.0315	CbGeAlD
Solifenacin—CHRM2—central nervous system—Parkinson's disease	0.000623	0.0303	CbGeAlD
Solifenacin—CHRM1—head—Parkinson's disease	0.000621	0.0303	CbGeAlD
Solifenacin—CHRM1—nervous system—Parkinson's disease	0.000589	0.0287	CbGeAlD
Solifenacin—CHRM1—central nervous system—Parkinson's disease	0.000567	0.0276	CbGeAlD
Solifenacin—CHRM3—head—Parkinson's disease	0.000556	0.0271	CbGeAlD
Solifenacin—CHRM3—nervous system—Parkinson's disease	0.000527	0.0257	CbGeAlD
Solifenacin—CHRM3—central nervous system—Parkinson's disease	0.000507	0.0247	CbGeAlD
Solifenacin—CHRM2—brain—Parkinson's disease	0.000495	0.0241	CbGeAlD
Solifenacin—CHRM1—brain—Parkinson's disease	0.00045	0.0219	CbGeAlD
Solifenacin—CHRM3—brain—Parkinson's disease	0.000403	0.0196	CbGeAlD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000394	0.000415	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.000389	0.000409	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—EDN1—Parkinson's disease	0.000388	0.000408	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	0.000388	0.000408	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000387	0.000407	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000385	0.000405	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.000384	0.000404	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—DDC—Parkinson's disease	0.000382	0.000401	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000382	0.000401	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000381	0.0004	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.00038	0.000399	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000378	0.000398	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000376	0.000395	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000373	0.000393	CbGpPWpGaD
Solifenacin—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000373	0.000392	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.000372	0.000391	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—EDN1—Parkinson's disease	0.000372	0.000391	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000369	0.000388	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—FGF20—Parkinson's disease	0.000366	0.000384	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000362	0.00038	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.000361	0.000379	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.000361	0.000379	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000357	0.000375	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ADORA2A—Parkinson's disease	0.000355	0.000373	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000354	0.000373	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—EDN1—Parkinson's disease	0.000353	0.000371	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000351	0.000369	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—FGF20—Parkinson's disease	0.00035	0.000368	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.00035	0.000368	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000349	0.000367	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.000348	0.000366	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000347	0.000365	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000346	0.000364	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.000345	0.000363	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.000344	0.000362	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.000341	0.000359	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00034	0.000357	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ADORA2A—Parkinson's disease	0.00034	0.000357	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000339	0.000357	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.000338	0.000355	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—EDN1—Parkinson's disease	0.000338	0.000355	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000338	0.000355	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000337	0.000354	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.000335	0.000352	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000333	0.000351	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000331	0.000348	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000331	0.000348	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.00033	0.000347	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.00033	0.000347	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000328	0.000345	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.000327	0.000344	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—INSR—Parkinson's disease	0.000327	0.000344	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000327	0.000344	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000327	0.000344	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.000326	0.000343	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.000326	0.000343	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000326	0.000343	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000326	0.000343	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000325	0.000342	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.000325	0.000341	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.000324	0.000341	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000323	0.00034	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000323	0.00034	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000321	0.000338	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000318	0.000335	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—INSR—Parkinson's disease	0.000313	0.00033	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—FGB—Parkinson's disease	0.000309	0.000325	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HTR2A—Parkinson's disease	0.000309	0.000324	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR1A—Parkinson's disease	0.000308	0.000324	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000307	0.000323	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000306	0.000321	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TAC1—Parkinson's disease	0.000303	0.000319	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000303	0.000318	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000302	0.000318	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.000301	0.000317	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000299	0.000314	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—DRD1—Parkinson's disease	0.000297	0.000312	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000297	0.000312	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000297	0.000312	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—FGB—Parkinson's disease	0.000296	0.000311	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.000296	0.000311	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.000296	0.000311	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	0.000295	0.000311	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	0.000295	0.00031	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000293	0.000308	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000293	0.000308	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	0.00029	0.000305	CbGpPWpGaD
Solifenacin—CYP3A4—nervous system—Parkinson's disease	0.00029	0.0141	CbGeAlD
Solifenacin—CHRM4—Signaling Pathways—DRD3—Parkinson's disease	0.000288	0.000303	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	0.000285	0.000299	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000284	0.000299	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000283	0.000298	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000281	0.000296	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000281	0.000295	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.00028	0.000295	CbGpPWpGaD
Solifenacin—CYP3A4—central nervous system—Parkinson's disease	0.000279	0.0136	CbGeAlD
Solifenacin—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.000278	0.000292	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	0.000276	0.00029	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ADRBK1—Parkinson's disease	0.000269	0.000283	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000268	0.000282	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000268	0.000282	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000263	0.000277	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000262	0.000275	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000261	0.000275	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—DRD2—Parkinson's disease	0.00026	0.000274	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR7—Parkinson's disease	0.00026	0.000274	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000259	0.000272	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	0.000257	0.000271	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000252	0.000265	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000252	0.000265	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000249	0.000262	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	0.000249	0.000262	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	0.000249	0.000262	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000249	0.000262	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000247	0.000259	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.000246	0.000258	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	0.000243	0.000256	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000239	0.000251	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000239	0.000251	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000239	0.000251	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000238	0.000251	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000238	0.00025	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.000237	0.000249	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000236	0.000248	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	0.000235	0.000247	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CTGF—Parkinson's disease	0.000234	0.000247	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000229	0.000241	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000228	0.00024	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000228	0.00024	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000226	0.000238	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000221	0.000232	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.00022	0.000231	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.000218	0.00023	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	0.000218	0.000229	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—INSR—Parkinson's disease	0.000218	0.000229	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NQO1—Parkinson's disease	0.000216	0.000227	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—TH—Parkinson's disease	0.000213	0.000224	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	0.000211	0.000222	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	0.000209	0.00022	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000209	0.000219	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	0.000208	0.000219	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000208	0.000219	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.000208	0.000219	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000207	0.000218	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000207	0.000218	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.000207	0.000217	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGB—Parkinson's disease	0.000206	0.000216	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000205	0.000216	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	0.000205	0.000215	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYCS—Parkinson's disease	0.000204	0.000215	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000204	0.000215	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000204	0.000214	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000203	0.000214	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000203	0.000214	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000203	0.000214	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	0.000202	0.000212	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	0.000202	0.000212	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.0002	0.000211	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.0002	0.00021	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	0.0002	0.00021	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	0.000198	0.000208	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000194	0.000204	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.000193	0.000203	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	0.000192	0.000201	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NGF—Parkinson's disease	0.000191	0.000201	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NGF—Parkinson's disease	0.000183	0.000193	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	0.000182	0.000192	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000181	0.000191	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—COMT—Parkinson's disease	0.000181	0.00019	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000181	0.00019	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.00018	0.000189	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MAOA—Parkinson's disease	0.00018	0.000189	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000179	0.000188	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.000178	0.000187	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000175	0.000185	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000175	0.000185	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.000175	0.000184	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.000175	0.000184	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	0.000175	0.000184	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	0.000173	0.000182	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	0.000173	0.000182	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.000171	0.000179	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—APOE—Parkinson's disease	0.000169	0.000178	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.000166	0.000174	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—APOE—Parkinson's disease	0.000162	0.000171	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GPX1—Parkinson's disease	0.000159	0.000167	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000149	0.000157	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000147	0.000155	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.000147	0.000154	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.000146	0.000154	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	0.000145	0.000153	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—INS—Parkinson's disease	0.000145	0.000152	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000142	0.00015	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.000142	0.000149	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000141	0.000148	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.00014	0.000148	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	0.00014	0.000148	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.00014	0.000147	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	0.000139	0.000146	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—INS—Parkinson's disease	0.000139	0.000146	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—APOE—Parkinson's disease	0.000136	0.000143	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000129	0.000136	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NGF—Parkinson's disease	0.000129	0.000135	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NGF—Parkinson's disease	0.000127	0.000134	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000127	0.000133	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000126	0.000132	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000123	0.000129	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	0.000123	0.000129	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	0.000121	0.000128	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—INS—Parkinson's disease	0.000116	0.000122	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000114	0.00012	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOE—Parkinson's disease	0.000114	0.00012	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOE—Parkinson's disease	0.000113	0.000119	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	0.000108	0.000113	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	0.000107	0.000113	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	0.000103	0.000109	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	0.000103	0.000108	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	9.9e-05	0.000104	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—INS—Parkinson's disease	9.76e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—INS—Parkinson's disease	9.73e-05	0.000102	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—INS—Parkinson's disease	9.63e-05	0.000101	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	9.49e-05	9.97e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.34e-05	9.82e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.16e-05	9.64e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	8.54e-05	8.98e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NQO1—Parkinson's disease	8.44e-05	8.88e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TH—Parkinson's disease	8.32e-05	8.75e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYCS—Parkinson's disease	7.99e-05	8.4e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	7.27e-05	7.64e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	7.24e-05	7.62e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	7.22e-05	7.59e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	7.2e-05	7.57e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	7.17e-05	7.54e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	7.13e-05	7.49e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—COMT—Parkinson's disease	7.08e-05	7.44e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.04e-05	7.41e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.03e-05	7.39e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HMOX1—Parkinson's disease	6.95e-05	7.3e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	6.68e-05	7.02e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.67e-05	7.01e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	6.66e-05	7e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	6.59e-05	6.93e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.47e-05	6.81e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—Parkinson's disease	6.33e-05	6.65e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.2e-05	6.52e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—Parkinson's disease	6.06e-05	6.37e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.72e-05	6.01e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOE—Parkinson's disease	5.32e-05	5.6e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—INS—Parkinson's disease	4.55e-05	4.78e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—Parkinson's disease	4.26e-05	4.48e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—Parkinson's disease	4.25e-05	4.47e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—Parkinson's disease	4.21e-05	4.43e-05	CbGpPWpGaD
